SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Evolent Health, Inc. – ‘10-K’ for 12/31/19

On:  Monday, 3/2/20, at 6:11am ET   ·   For:  12/31/19   ·   Accession #:  1628908-20-32   ·   File #:  1-37415

Previous ‘10-K’:  ‘10-K’ on 2/28/19 for 12/31/18   ·   Next:  ‘10-K’ on 2/26/21 for 12/31/20   ·   Latest:  ‘10-K’ on 2/23/24 for 12/31/23   ·   2 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 3/02/20  Evolent Health, Inc.              10-K       12/31/19  150:20M

Annual Report   —   Form 10-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   2.78M 
 2: EX-4.8      Instrument Defining the Rights of Security Holders  HTML     64K 
 3: EX-21.1     Subsidiaries List                                   HTML     42K 
 4: EX-23.1     Consent of Experts or Counsel                       HTML     40K 
 5: EX-23.2     Consent of Experts or Counsel                       HTML     40K 
 6: EX-31.1     Certification -- §302 - SOA'02                      HTML     48K 
 7: EX-31.2     Certification -- §302 - SOA'02                      HTML     48K 
 8: EX-32.1     Certification -- §906 - SOA'02                      HTML     42K 
 9: EX-32.2     Certification -- §906 - SOA'02                      HTML     42K 
133: R1          Cover Page                                          HTML    105K  
79: R2          Consolidated Balance Sheets                         HTML    162K 
30: R3          Consolidated Balance Sheets (Parenthetical)         HTML     52K 
112: R4          Consolidated Statements of Operations and           HTML    138K  
                Comprehensive Income (Loss)                                      
134: R5          Consolidated Statements of Changes in               HTML    144K  
                Shareholders' Equity (Deficit)                                   
80: R6          Consolidated Statements of Cash Flows               HTML    166K 
31: R7          Organization                                        HTML     48K 
115: R8          Basis of Presentation, Summary of Significant       HTML    149K  
                Accounting Policies and Change in Accounting                     
                Principle                                                        
132: R9          Recently Issued Accounting Standards                HTML     51K  
136: R10         Transactions                                        HTML    155K  
84: R11         Revenue Recognition                                 HTML     94K 
38: R12         Property and Equipment, Net                         HTML     58K 
55: R13         Goodwill and Intangible Assets, Net                 HTML    127K 
137: R14         Long-term Debt                                      HTML     97K  
85: R15         Commitments and Contingencies                       HTML    108K 
39: R16         Leases                                              HTML     80K 
56: R17         Earnings (Loss) Per Common Share                    HTML     76K 
135: R18         Stock-based Compensation                            HTML    186K  
86: R19         Income Taxes                                        HTML    202K 
28: R20         Employee Benefit Plans                              HTML     43K 
82: R21         Investments In and Advances to Equity Method        HTML     97K 
                Investees                                                        
130: R22         Non-controlling Interests                           HTML     73K  
113: R23         Fair Value Measurement                              HTML    168K  
29: R24         Related Parties                                     HTML     76K 
83: R25         Segment Reporting                                   HTML    173K 
131: R26         Reserves for Claims and performance-Based           HTML     98K  
                Arrangements                                                     
114: R27         Investments                                         HTML    105K  
33: R28         Quarterly Results of Operations (Unaudited)         HTML     93K 
81: R29         Supplemental Cash Flow Information                  HTML     83K 
53: R30         Basis of Presentation, Summary of Significant       HTML    245K 
                Accounting Policies and Change in Accounting                     
                Principle (Policies)                                             
37: R31         Basis of Presentation, Summary of Significant       HTML    140K 
                Accounting Policies and Change in Accounting                     
                Principle (Tables)                                               
88: R32         Transactions (Tables)                               HTML     90K 
139: R33         Revenue Recognition (Tables)                        HTML     74K  
52: R34         Property and Equipment, Net (Tables)                HTML     58K 
36: R35         Goodwill and Intangible Assets, Net (Tables)        HTML    120K 
87: R36         Long-term Debt (Tables)                             HTML     58K 
138: R37         Commitments and Contingencies (Tables)              HTML     78K  
54: R38         Leases (Tables)                                     HTML     75K 
34: R39         Earnings (Loss) Per Common Share (Tables)           HTML     79K 
75: R40         Stock-based Compensation (Tables)                   HTML    167K 
27: R41         Income Taxes (Tables)                               HTML    192K 
100: R42         Investments In and Advances to Equity Method        HTML     90K  
                Investees Investments In and Advances to Equity                  
                Method Investees (Tables)                                        
120: R43         Non-controlling Interests (Tables)                  HTML     55K  
73: R44         Fair Value Measurement (Tables)                     HTML    219K 
25: R45         Related Parties (Tables)                            HTML     71K 
99: R46         Segment Reporting (Tables)                          HTML    170K 
118: R47         Reserves for Claims and performance-Based           HTML     91K  
                Arrangements (Tables)                                            
76: R48         Investments (Tables)                                HTML    106K 
22: R49         Quarterly Results of Operations (Unaudited)         HTML     93K 
                (Tables)                                                         
46: R50         Supplemental Cash Flow Information (Tables)         HTML     82K 
65: R51         Organization (Details)                              HTML     45K 
140: R52         Basis of Presentation, Summary of Significant       HTML     41K  
                Accounting Policies and Change in Accounting                     
                Principle - Operating Segments (Details)                         
91: R53         Basis of Presentation, Summary of Significant       HTML     89K 
                Accounting Policies and Change in Accounting                     
                Principle - Restricted Cash and Restricted                       
                Investments (Details)                                            
48: R54         Basis of Presentation, Summary of Significant       HTML     57K 
                Accounting Policies and Change in Accounting                     
                Principle - Notes Receivable (Details)                           
66: R55         Basis of Presentation, Summary of Significant       HTML     52K 
                Accounting Policies and Change in Accounting                     
                Principle - Estimated Useful Life of Property,                   
                Plant and Equipment (Details)                                    
141: R56         Basis of Presentation, Summary of Significant       HTML     44K  
                Accounting Policies and Change in Accounting                     
                Principle - Research and Development Costs                       
                (Details)                                                        
92: R57         Basis of Presentation, Summary of Significant       HTML     42K 
                Accounting Policies and Change in Accounting                     
                Principle - Goodwill (Details)                                   
50: R58         Basis of Presentation, Summary of Significant       HTML     53K 
                Accounting Policies and Change in Accounting                     
                Principle - Intangible Assets, Net (Details)                     
62: R59         Basis of Presentation, Summary of Significant       HTML     43K 
                Accounting Policies and Change in Accounting                     
                Principle - Impairment of Equity Method                          
                Investments (Details)                                            
126: R60         Basis of Presentation, Summary of Significant       HTML     45K  
                Accounting Policies and Change in Accounting                     
                Principle - Revenue Recognition (Details)                        
104: R61         Basis of Presentation, Summary of Significant       HTML     45K  
                Accounting Policies and Change in Accounting                     
                Principle - Stock-based Compensation (Details)                   
18: R62         Recently Issued Accounting Standards (Details)      HTML     47K 
67: R63         Transactions - Passport (Details)                   HTML     71K 
129: R64         Transactions - New Century Health (Details)         HTML    144K  
107: R65         Transactions - New Mexico Health Connections        HTML     83K  
                (Details)                                                        
21: R66         Transactions - Pro Forma Information (Unaudited)    HTML     55K 
                (Details)                                                        
70: R67         Transactions - Securities Offerings and Sales       HTML    143K 
                (Details)                                                        
122: R68         Transactions - Asset Acquisitions (Details)         HTML     53K  
109: R69         Revenue Recognition - Disaggregation of Revenue     HTML     59K  
                (Details)                                                        
98: R70         Revenue Recognition - Transaction Price Allocated   HTML     45K 
                to the Remaining Performance Obligations (Details)               
147: R71         Revenue Recognition - Contract Balances (Details)   HTML     80K  
60: R72         Revenue Recognition - Contract Costs (Details)      HTML     52K 
44: R73         Property and Equipment, Net (Details)               HTML     68K 
95: R74         Goodwill and Intangible Assets, Net - Impairment    HTML     59K 
                Testing (Details)                                                
144: R75         Goodwill and Intangible Assets, Net - Schedule of   HTML     63K  
                Goodwill (Details)                                               
57: R76         Goodwill and Intangible Assets, Net - Intangible    HTML     71K 
                Assets, Net (Details)                                            
41: R77         Goodwill and Intangible Assets, Net - Amortization  HTML     57K 
                of Intangible Assets (Details)                                   
94: R78         Long-term Debt - Credit Agreement (Details)         HTML     84K 
149: R79         Long-term Debt - Warrant Agreement (Details)        HTML     47K  
97: R80         Long-term Debt - 2025 Notes (Details)               HTML     92K 
146: R81         Long-term Debt - 2021 Notes (Details)               HTML     78K  
59: R82         Long-term Debt - Convertible Senior Notes Carrying  HTML     73K 
                Value (Details)                                                  
43: R83         Commitments and Contingencies - Additional          HTML     95K 
                Information (Details)                                            
96: R84         Commitments and Contingencies - Purchase            HTML     49K 
                Obligations (Details)                                            
145: R85         Commitments and Contingencies - Reinsurance         HTML     54K  
                Agreements (Details)                                             
58: R86         Commitments and Contingencies - Concentration Risk  HTML     65K 
                (Details)                                                        
42: R87         Leases - Narratives (Details)                       HTML     51K 
93: R88         Leases - Material Office Leases (Details)           HTML     63K 
148: R89         Leases - Components of Lease Expense (Details)      HTML     52K  
127: R90         Leases - Maturity of Lease Liabilities (Details)    HTML     62K  
105: R91         Leases - Weighted-average Discount Rate and         HTML     44K  
                Weighted-remaining Lease Terms (Details)                         
19: R92         Earnings (Loss) Per Common Share - Computation of   HTML     74K 
                Earnings per Share (Details)                                     
68: R93         Earnings (Loss) Per Common Share - Antidilutive     HTML     54K 
                Securities (Details)                                             
128: R94         Stock-based Compensation - 2011 and 2015 Equity     HTML     64K  
                Incentive Plans (Details)                                        
106: R95         Stock-based Compensation - Stock-based              HTML     63K  
                Compensation Expense (Details)                                   
20: R96         Stock-based Compensation - Unrecognized             HTML     59K 
                Compensation Expense (Details)                                   
69: R97         Stock-based Compensation - Stock Options (Details)  HTML     74K 
124: R98         Stock-based Compensation - Stock Option Activity    HTML     95K  
                (Details)                                                        
111: R99         Stock-based Compensation - Performance-based Stock  HTML    115K  
                Option Awards (Details)                                          
23: R100        Stock-based Compensation - Restricted Stock Units   HTML     85K 
                (Details)                                                        
77: R101        Stock-based Compensation - Leveraged Stock Units    HTML     75K 
                (Details)                                                        
116: R102        Stock-based Compensation - Leveraged Stock Units    HTML     62K  
                Activity (Details)                                               
101: R103        Stock-based Compensation - Performance-based RSUs   HTML     65K  
                (Details)                                                        
24: R104        Income Taxes - Narrative (Details)                  HTML     95K 
78: R105        Income Taxes - Schedule of Loss Before Provision    HTML     48K 
                for Income Taxes (Details)                                       
117: R106        Income Taxes - Income Tax Expense (Benefit)         HTML     75K  
                (Details)                                                        
102: R107        Income Taxes - Reconciliation of Statutory Rate to  HTML     86K  
                Effective Tax Rate (Details)                                     
26: R108        Income Taxes - Deferred Tax Assets and Liabilities  HTML    105K 
                (Details)                                                        
74: R109        Income Taxes - Changes in Valuation Allowance       HTML     51K 
                (Details)                                                        
63: R110        Income Taxes - Changes In Unrecognized Tax          HTML     56K 
                Benefits (Details)                                               
51: R111        Employee Benefit Plans (Details)                    HTML     42K 
90: R112        Investments In and Advances to Equity Method        HTML     87K 
                Investees (Details)                                              
143: R113        Investments In and Advances to Equity Method        HTML     75K  
                Investees - Schedule of Assets and Liabilities and               
                Maximum Loss Exposure of Unconsolidated VIEs                     
                (Details)                                                        
61: R114        Investments In and Advances to Affiliates -         HTML     77K 
                Summarized Financial Information (Details)                       
49: R115        Non-controlling Interests (Details)                 HTML    155K 
89: R116        Fair Value Measurement - Assets and Liabilities on  HTML     84K 
                Recurring Basis (Details)                                        
142: R117        Fair Value Measurement (Details)                    HTML     50K  
64: R118        Fair Value Measurement - Changes in Contingent      HTML     51K 
                Consideration and Other (Details)                                
45: R119        Fair Value Measurement - Valuation Techniques and   HTML    100K 
                Significant Unobservable Inputs (Details)                        
110: R120        Related Parties (Details)                           HTML     45K  
123: R121        Related Parties - Assets and Liabilities (Details)  HTML     68K  
72: R122        Related Parties - Revenues and Expenses (Details)   HTML     68K 
17: R123        Segment Reporting (Details)                         HTML    109K 
108: R124        Segment Reporting - Reconciliation of Adjusted      HTML     98K  
                EBITDA (Details)                                                 
121: R125        Reserves for Claims and performance-Based           HTML     70K  
                Arrangements - Claims Reserves (Details)                         
71: R126        Investments - Investment Summary (Details)          HTML     63K 
15: R127        Investments - Contractual Maturity (Details)        HTML     66K 
103: R128        Investments - Unrealized Losses (Details)           HTML     49K  
125: R129        Quarterly Results of Operations (Unaudited)         HTML     68K  
                (Details)                                                        
150: R130        Supplemental Cash Flow Information (Details)        HTML     94K  
47: R9999       Uncategorized Items - evh12311910-k.htm             HTML     42K 
40: XML         IDEA XML File -- Filing Summary                      XML    285K 
32: XML         XBRL Instance -- evh12311910-k_htm                   XML   5.24M 
119: EXCEL       IDEA Workbook of Financial Reports                  XLSX    198K  
11: EX-101.CAL  XBRL Calculations -- evh-20191231_cal                XML    432K 
12: EX-101.DEF  XBRL Definitions -- evh-20191231_def                 XML   1.64M 
13: EX-101.LAB  XBRL Labels -- evh-20191231_lab                      XML   3.24M 
14: EX-101.PRE  XBRL Presentations -- evh-20191231_pre               XML   2.23M 
10: EX-101.SCH  XBRL Schema -- evh-20191231                          XSD    330K 
16: JSON        XBRL Instance as JSON Data -- MetaLinks              667±  1.06M 
35: ZIP         XBRL Zipped Folder -- 0001628908-20-000032-xbrl      Zip    748K 




        
Filing Submission 0001628908-20-000032 – SGML Text

Original SGML Text submitted by:  Evolent Health, Inc.

To view the SGML, please refresh
Refresh emoji
this page.


Top

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Mon., Apr. 29, 10:56:44.2am ET